News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Gayatri C. Patel

Advertisement

Articles by Gayatri C. Patel

Formulation of Modified Liquid-Solid Compact for Dissolution Enhancement of Raloxifene Hydrochloride

ByGayatri C. Patel,Dharmang Pandya,Pushti Gandhi,Rajesh Parikh
July 3rd 2021

The purpose of this research was to formulate modified liquisolid compacts (MLSC) of RLX for improved dissolution in immediate-release tablet formulations.

Development of Taste-Masked Oral Reconstitutable Suspension of Cetirizine Dihydrochloride

ByGayatri C. Patel
January 2nd 2020

The aim of this study was to prepare taste-masked drug-resin complex using ion exchange resin Kyron T-134.

Advertisement

Latest Updated Articles

  • Formulation of Modified Liquid-Solid Compact for Dissolution Enhancement of Raloxifene Hydrochloride
    Formulation of Modified Liquid-Solid Compact for Dissolution Enhancement of Raloxifene Hydrochloride

    Published: July 3rd 2021 | Updated:

  • Development of Taste-Masked Oral Reconstitutable Suspension of Cetirizine Dihydrochloride
    Development of Taste-Masked Oral Reconstitutable Suspension of Cetirizine Dihydrochloride

    Published: January 2nd 2020 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape

2

Clearing Hurdles in Sustainability, AI, and CDMO Partnerships

3

Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One

4

PharmTech Weekly News Roundup — Week of October 27, 2025

5

Takeda’s Sriman Banerjee Discusses Smart Packaging at CPHI Frankfurt 2025

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us